Teradyne (NASDAQ:TER – Get Free Report) was downgraded by equities researchers at Zacks Research from a “strong-buy” rating to a “hold” rating in a report released on Monday,Zacks.com reports.
A number of other brokerages also recently weighed in on TER. Vertical Research downgraded Teradyne from a “buy” rating to a “hold” rating and set a $220.00 price target for the company. in a report on Friday, January 9th. Bank of America increased their price target on Teradyne from $250.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, January 22nd. Susquehanna increased their price target on Teradyne from $335.00 to $415.00 and gave the stock a “positive” rating in a report on Thursday, April 9th. TD Cowen reiterated a “buy” rating on shares of Teradyne in a report on Thursday, January 22nd. Finally, Morgan Stanley set a $306.00 price target on Teradyne in a report on Wednesday, February 11th. Ten equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $289.53.
Read Our Latest Analysis on TER
Teradyne Trading Down 2.1%
Teradyne (NASDAQ:TER – Get Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.44. Teradyne had a return on equity of 22.68% and a net margin of 17.37%.The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $970.44 million. During the same period last year, the business posted $0.95 EPS. The business’s revenue was up 43.9% compared to the same quarter last year. Equities research analysts predict that Teradyne will post 3.88 earnings per share for the current fiscal year.
Institutional Trading of Teradyne
Several large investors have recently made changes to their positions in TER. ARK Investment Management LLC boosted its stake in Teradyne by 25.2% during the 3rd quarter. ARK Investment Management LLC now owns 2,722,327 shares of the company’s stock valued at $374,701,000 after purchasing an additional 548,140 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH boosted its stake in Teradyne by 9.2% during the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 91,120 shares of the company’s stock valued at $12,542,000 after purchasing an additional 7,648 shares during the last quarter. Aspen Wealth Strategies LLC acquired a new position in Teradyne during the 3rd quarter valued at about $577,000. Assenagon Asset Management S.A. boosted its stake in Teradyne by 3,233.4% during the 4th quarter. Assenagon Asset Management S.A. now owns 910,023 shares of the company’s stock valued at $176,144,000 after purchasing an additional 882,723 shares during the last quarter. Finally, Thrivent Financial for Lutherans boosted its stake in Teradyne by 291.6% during the 2nd quarter. Thrivent Financial for Lutherans now owns 24,995 shares of the company’s stock valued at $2,247,000 after purchasing an additional 18,612 shares during the last quarter. 99.77% of the stock is currently owned by institutional investors and hedge funds.
About Teradyne
Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.
The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.
Read More
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.
